Medicament Device Evaluation Using Segmented Demonstration Units
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medicament delivery device design processes are inefficient due to the lack of effective communication between mechanical and electronic engineers, leading to significant time and cost expenditures in prototype development and testing, as well as limitations in simulating real-world indications such as light and vibration in software simulations.
Innovation Solution
A medicament delivery device design evaluation apparatus comprising a plurality of electronic demonstration units with data receivers and indication units, allowing for real-time selection and observation of visual, audible, and tactile indications in a real environment, facilitated by a control device with a user interface, communication unit, and processors to send control signals to the demonstration units.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If software simulation is used to evaluate design indications, then development time is reduced, but the accuracy of representing real-world performance deteriorates
Solution Approach 1:
The patent creates physical copies (demonstration units) of the electronic indication components that can be independently tested and evaluated. These demonstration units are simplified replicas that replicate the core functionality of the actual device indications, allowing realistic evaluation without building complete prototypes.
Solution Approach 2:
The patent segments the evaluation process by separating the indication components from the complete device. Each demonstration unit represents a specific indication component (light, vibration, sound) that can be independently evaluated, allowing teams to assess multiple indications simultaneously without integrating them into a full device prototype.
2Manufacturing precision
If physical prototypes are repeatedly modified to match engineer expectations, then design accuracy is improved, but development cost and time increase
Solution Approach 1:
The patent divides the device into separate demonstration units, each representing a specific indication component. This segmentation allows mechanical and electronic engineers to evaluate their respective components independently and simultaneously, eliminating the sequential iteration process where mechanical prototypes must be built before electronic functions can be tested.
Solution Approach 2:
The demonstration units are prepared in advance as independent evaluation tools before final device integration. This preliminary action allows design teams to identify and resolve issues with individual indication components early in the design process, preventing costly revisions later when components are integrated into the complete device.
3Adaptability or versatility
If communication between mechanical and electronic engineers is facilitated through simultaneous evaluation, then design coordination is improved, but system complexity increases
Solution Approach 1:
The patent segments the evaluation system into independent demonstration units for different indication types (visual, tactile, audible). Each unit is self-contained with its own control electronics, allowing multiple engineers to evaluate different aspects simultaneously without complex interconnections or centralized control systems.
Data Source
AI summary
A medicament delivery device design evaluation apparatus is presented having a plurality of electronic demonstration units, wherein each electronic demonstration unit comprises a set of electronics, the set of electronics comprising a data receiver and at least one of an indication unit and a data transmitter, wherein the plurality of electronic demonstration units are configured to provide an indication when at least one of the plurality of electronic demonstration units receives a control signal.